Sialyl Lewis(a): a tumor-associated carbohydrate antigen involved in adhesion and metastatic potential of cancer cells.
about
Hallmarks of glycosylation in cancerRegulation of the metastatic cell phenotype by sialylated glycansA Sialyltransferase Mutant with Decreased Donor Hydrolysis and Reduced Sialidase Activities for Directly Sialylating Lewis xProstatic cell-specific regulation of the synthesis of MUC1-associated sialyl Lewis aAn ultrasound contrast agent targeted to P-selectin detects activated platelets at supra-arterial shear flow conditions.Knockdown of fucosyltransferase III disrupts the adhesion of circulating cancer cells to E-selectin without affecting hematopoietic cell adhesionSialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression.Human a-L-fucosidase-1 attenuates the invasive properties of thyroid cancer.Enhancive effects of Lewis y antigen on CD44-mediated adhesion and spreading of human ovarian cancer cell line RMG-I.N-acetylglucosamine: production and applicationsN-glycosylation of colorectal cancer tissues: a liquid chromatography and mass spectrometry-based investigation.Increased expression of sialic acid in cervical biopsies with squamous intraepithelial lesionsHuman monoclonal antibodies to sialyl-Lewis (CA19.9) with potent CDC, ADCC, and antitumor activityCancer vaccines and carbohydrate epitopes.Detection of the potential pancreatic cancer marker MUC4 in serum using surface-enhanced Raman scatteringGlycosyltransferases involved in the synthesis of MUC-associated metastasis-promoting selectin ligands.Serum level of TSGF, CA242 and CA19-9 in pancreatic cancer.MEDULLARY THYROID CANCER THAT STAINS NEGATIVE FOR CA 19-9 HAS DECREASED METASTATIC POTENTIAL.Advances in biomarker research for pancreatic cancer.CA 19-9 and pancreatic cancer.Changes in H5N1 influenza virus hemagglutinin receptor binding domain affect systemic spread.The use of a novel MUC1 antibody to identify cancer stem cells and circulating MUC1 in mice and patients with pancreatic cancer.The engagement of selectins and their ligands in colorectal cancer liver metastases.Sweet and sour: the impact of differential glycosylation in cancer cells undergoing epithelial-mesenchymal transition.Cloning and characterization of a viral α2-3-sialyltransferase (vST3Gal-I) for the synthesis of sialyl Lewisx.Glycan-related gene expression signatures in human metastatic hepatocellular carcinoma cells.Serum N-glycan analysis in breast cancer patients--Relation to tumour biology and clinical outcome.Tumour markers and kidney function: a systematic review.Sequential two-step multienzyme synthesis of tumor-associated sialyl T-antigens and derivatives.E-Selectin Ligands in the Human Mononuclear Phagocyte System: Implications for Infection, Inflammation, and Immunotherapy.
P2860
Q26752363-E26D1BCD-2422-453B-A069-0D70F8BBC95AQ27027559-C8550481-4222-4479-9B2E-F4D0C8945902Q27679080-27FAC101-0D7C-4411-83EB-2283288EF94DQ28486623-BFFD7DD9-0F34-4A4C-A67F-32E165789C4DQ30425444-0798DF0D-5B03-410F-BB4C-996F865608F4Q30497537-320F360C-637E-46EA-BB2E-E3199F1D8DB6Q33290245-FC60AF42-A47C-47AE-824C-1F554C17A65FQ33688938-7BDB7851-B10F-4159-B1FA-A2A917C7325EQ33812159-EDB1C7CE-C2C1-4992-8C8E-40A2CD2207DBQ34191432-630A8E8D-34BA-4ABC-9FA1-367A5675A31EQ34264310-9EC0325B-9137-4680-ACE6-87B20BB382B3Q34380061-720D29A7-32B5-4CC3-8E9D-6DBDA778E28FQ34782050-99F3ED3D-76FC-4342-9FA8-BE7207EAED03Q35525289-C8D66513-C852-4CFB-9172-35B29C167340Q35860052-2D37379C-7545-40FA-AC9E-DE331FF8C808Q35899406-18843BA0-BAD7-4682-966C-AC38784C3CA3Q36067547-725E5ADC-5A41-4A0B-8296-D6E03FD0CE37Q36069550-9E5B9DEE-4332-4CE4-BADC-6E982BC1F8D9Q36126609-81BC2FCE-B163-4057-A46B-3D5B12DA3A2EQ36786361-27FE5C63-EE58-4ED4-9AFB-2598917C9BADQ37068350-FA875883-C7EF-4812-89A9-EE930E093B26Q37434103-D14D4268-21A5-4FA6-AF38-4FFC425429E7Q37559776-C1E943D1-F4E3-42C3-AB4D-7A331AF29AD5Q38203883-A1AD3E24-333D-4884-B26E-E8213E1DB256Q38339801-431B71B5-D2A0-4911-AE3A-9702B1E37D17Q39280651-5FA6C665-0434-4205-BD96-C2581AFFFA45Q40592492-EFDD9774-5D5E-4F86-B631-3B61FDFFE552Q41858828-3571688E-9C5C-48A1-96A7-0A85ADB1CBC7Q42757284-60B79DB4-27DE-48A5-AE64-6ABDED0596B5Q50197234-ABE1919F-1568-4190-BA8E-DD2307730840
P2860
Sialyl Lewis(a): a tumor-associated carbohydrate antigen involved in adhesion and metastatic potential of cancer cells.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Sialyl Lewis
@nl
Sialyl Lewis(a): a tumor-assoc ...... tic potential of cancer cells.
@ast
Sialyl Lewis(a): a tumor-assoc ...... tic potential of cancer cells.
@en
type
label
Sialyl Lewis
@nl
Sialyl Lewis(a): a tumor-assoc ...... tic potential of cancer cells.
@ast
Sialyl Lewis(a): a tumor-assoc ...... tic potential of cancer cells.
@en
prefLabel
Sialyl Lewis
@nl
Sialyl Lewis(a): a tumor-assoc ...... tic potential of cancer cells.
@ast
Sialyl Lewis(a): a tumor-assoc ...... tic potential of cancer cells.
@en
P1476
Sialyl Lewis(a): a tumor-assoc ...... atic potential of cancer cells
@en
P2093
Anna Laskowska
Maciej Ugorski
P304
P577
2002-01-01T00:00:00Z